Skip to main content
Equibles

NewEdge Advisors, LLC

Position in LTRN — Lantern Pharma Inc.

CIK 1633516 NEW ORLEANS, LA
Back to LTRN Full portfolio

Position in LTRN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$112,794
+$75,258 QoQ
Shares Held
27,049
-1.3% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 39 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LTRN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. LTRN ranks #40 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 18,435 $9,157,217
2 REGN
Regeneron Pharmaceuticals, Inc.
 11,911 $7,426,984
3 NUVB
Nuvation Bio Inc.
 1,231,733 $6,996,243
4 INCY
Incyte Corp
 34,605 $3,922,822
5 PHAT
Phathom Pharmaceuticals, Inc.
 203,962 $2,212,987
6 EXEL
Exelixis, Inc.
 32,532 $1,770,066
7 BMRN
Biomarin Pharmaceutical Inc
 27,287 $1,561,362
8 RPRX
Royalty Pharma plc
 21,597 $1,210,943

All Filings in LTRN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $112,794 27,049
2026-03-31 $37,536 27,399
2025-12-31 $115,349 38,069
2025-09-30 $205,663 47,279
2025-06-30 $178,562 56,507
2025-03-31 $212,130 59,924
2024-12-31 $218,065 68,359
2024-09-30 $504,030 137,338
2024-06-30 $733,769 157,124
2024-03-31 $1,412,681 160,532
2023-12-31 $710,360 165,972
2023-09-30 $579,805 170,031
2023-06-30 $967,062 171,465
2023-03-31 $831,315 172,115
2022-12-31 $1,043,941 172,838
2022-09-30 $817,470 171,019
2022-06-30 $970,540 169,972
2022-03-31 $1,213,862 169,771
2021-12-31 $1,333,505 167,106
2021-09-30 $1,742,503 155,859
2021-06-30 $2,209,213 151,316